Terms: = Lymphoma AND KMT2D, ENSG00000167548, 8085, MLL2
225 results:
1. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
[TBL] [Abstract] [Full Text] [Related]
2. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
3. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of the feasibility and prognostic value of circulating tumor DNA monitoring in detecting gene mutations in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy].
Zhou LH; Feng YQ; Hu YX; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):805-812. PubMed ID: 38049331
[No Abstract] [Full Text] [Related]
5. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Wu G; Yoshida N; Liu J; Zhang X; Xiong Y; Heavican-Foral TB; Mandato E; Liu H; Nelson GM; Yang L; Chen R; Donovan KA; Jones MK; Roshal M; Zhang Y; Xu R; Nirmal AJ; Jain S; Leahy C; Jones KL; Stevenson KE; Galasso N; Ganesan N; Chang T; Wu WC; Louissaint A; Debaize L; Yoon H; Dal Cin P; Chan WC; Ho Sui SJ; Ng SY; Feldman AL; Horwitz SM; Adelman K; Fischer ES; Chen CW; Weinstock DM; Brown M
Sci Transl Med; 2023 Sep; 15(714):eadi7244. PubMed ID: 37729434
[TBL] [Abstract] [Full Text] [Related]
6. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
Veltmaat N; Zhong Y; de Jesus FM; Tan GW; Bult JAA; Terpstra MM; Mutsaers PGNJ; Stevens WBC; Mous R; Vermaat JSP; Chamuleau MED; Noordzij W; Verschuuren EAM; Kok K; Kluiver JL; Diepstra A; Plattel WJ; van den Berg A; Nijland M
J Hematol Oncol; 2023 Sep; 16(1):104. PubMed ID: 37705050
[TBL] [Abstract] [Full Text] [Related]
7. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
[TBL] [Abstract] [Full Text] [Related]
8. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract] [Full Text] [Related]
9. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
[TBL] [Abstract] [Full Text] [Related]
10. Histone methyltransferase kmt2d inhibits ENKTL carcinogenesis by epigenetically activating SGK1 and SOCS1.
Zhang YH; Tao Q; Zhang WY; Zhao S; Liu WP; Gao LM
Genes Genomics; 2024 Feb; 46(2):203-212. PubMed ID: 37523130
[TBL] [Abstract] [Full Text] [Related]
11. Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.
Eadie LN; Rehn JA; Schutz CE; Heatley SL; Kutyna MM; Hiwase DK; White DL; Yeung DT
Br J Haematol; 2023 Oct; 203(2):282-287. PubMed ID: 37519213
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma.
Sung HJ; Kim D; Yoon DH; Cho H; Huh J; Suh CW; Go H
Hum Pathol; 2023 Sep; 139():106-116. PubMed ID: 37517597
[TBL] [Abstract] [Full Text] [Related]
13. Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various lymphoma Subtypes.
Kim JJ; Kim HM; Kim H; Kim SJ; Lee ST; Choi JR; Shin S; Hwang DY
Cancer Res Treat; 2024 Jan; 56(1):314-323. PubMed ID: 37475138
[TBL] [Abstract] [Full Text] [Related]
14. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
15. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
16. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A; Martín-Muñoz A; Poza M; Dorado S; García-Ortiz A; Revilla E; Sarandeses P; Ruiz-Heredia Y; Baumann T; Rodríguez A; Calbacho M; Sánchez PM; Pina JMS; García-Sancho AM; Figaredo G; Rufián L; Rodríguez M; Carneros L; Martínez-Laperche C; Bastos-Oreiro M; Wang C; Cedena MT; Rapado I; de Toledo P; Gallardo M; Valeri A; Ayala R; Martínez-López J; Barrio S
Front Immunol; 2023; 14():1188818. PubMed ID: 37342332
[TBL] [Abstract] [Full Text] [Related]
17. kmt2d Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition.
Xu J; Zhong A; Zhang S; Chen M; Zhang L; Hang X; Zheng J; Wu B; Deng X; Pan X; Wang Z; Qi L; Shi K; Li S; Wang Y; Wang M; Chen X; Zhang Q; Liu P; Gale RP; Chen C; Liu Y; Niu T
Adv Sci (Weinh); 2023 Jul; 10(19):e2206098. PubMed ID: 37142882
[TBL] [Abstract] [Full Text] [Related]
18. A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and kmt2d.
Fukatsu M; Hamazaki Y; Sato Y; Koyama D; Ikezoe T
Int J Hematol; 2023 Oct; 118(4):472-476. PubMed ID: 37133636
[TBL] [Abstract] [Full Text] [Related]
19. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
20. Nationwide analysis of adult hospitalizations with hemophagocytic lymphohistiocytosis and systemic lupus erythematosus.
Noboa MER; Lopez-Arevalo H; Patel AR; Arora S; Manadan AM
Clin Rheumatol; 2023 Aug; 42(8):2091-2095. PubMed ID: 37081184
[TBL] [Abstract] [Full Text] [Related]
[Next]